Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yu Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7935-9902; OpenAlex author ID A5100445097. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2022: 3 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 6

  1. Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal aden… Co-author DOI 10.1016/j.biomaterials.2025.123630↗
  2. Cascade-Targeted Nanoparticles for Enhanced Gemcitabine Delivery and Adenosine Metabolism Modulation to Overcome Treatment Resistance in Pancreatic Cancer. Co-author DOI 10.1002/advs.202507118↗
  3. Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy. Co-author DOI 10.1021/acs.nanolett.4c06372↗
  4. Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment. Co-author DOI 10.1002/smll.202107712↗
  5. Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2021.121306↗
  6. Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2022.121599↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chen Jiang · 6 shared papers, 2022–2026 · strength 1.13
  2. Tao Sun · 5 shared papers, 2022–2026 · strength 0.89
  3. Haolin Song · 4 shared papers, 2022–2026 · strength 0.86
  4. Qinjun Chen · 4 shared papers, 2022–2026 · strength 0.77
  5. Hongrui Fan · 3 shared papers, 2025–2026 · strength 0.74
  6. Hongyi Chen · 3 shared papers, 2022–2025 · strength 0.48
  7. Yifan Luo · 3 shared papers, 2022 · strength 0.39
  8. Chufeng Li · 2 shared papers, 2022–2025 · strength 0.36
  9. Shilin Zhang · 1 shared paper, 2025 · strength 0.20
  10. Qingbing Wang · 1 shared paper, 2022 · strength 0.15
  11. Yu Zhou · 1 shared paper, 2022 · strength 0.12
  12. Chen Liang · 1 shared paper, 2022 · strength 0.12
  13. Wenxi Zhou · 1 shared paper, 2022 · strength 0.12
  14. Xianjun Yu · 1 shared paper, 2022 · strength 0.12
  15. Xinli Chen · 1 shared paper, 2022 · strength 0.12
  16. Si Shi · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.